Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.

Jaspard, Marie; Butel, Nathalie; El Helali, Najoua; Marigot-Outtandy, Dhiba; Guillot, Helene; Peytavin, Gilles; Veziris, Nicolas; Bodaghi, Bahram; Flandre, Philippe; Petitjean, Gregoire; Caumes, Eric; Pourcher, Valerie

Jaspard, Marie; Butel, Nathalie; El Helali, Najoua; Marigot-Outtandy, Dhiba; Guillot, Helene; Peytavin, Gilles; Veziris, Nicolas; Bodaghi, Bahram; Flandre, Philippe; Petitjean, Gregoire; Caumes, Eric; Pourcher, Valerie.

Emerg Infect Dis ; 26(8): 1792-1800, 2020 08.

Article in En | MEDLINE | ID: mdl-32687026

Subject(s)

Antitubercular Agents; Tuberculosis, Multidrug-Resistant; Antitubercular Agents/adverse effects; France/epidemiology; Humans; Linezolid/adverse effects; Treatment Outcome; Tuberculosis, Multidrug-Resistant/drug therapy; Tuberculosis, Multidrug-Resistant/epidemiology

Key words

France; MDR TB; TB; Tuberculosis; XDR TB; linezolid; neurologic events; neuropathy; pharmacokinetics; tuberculosis and other mycobacteria

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Emerg Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2020 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google